2301 - 2325 of 8785 Results
Title
Year
- Including People with Parkinson’s Disease in Clinical Study Design and Execution: A Call to Action2022OPENTitle: Including People with Parkinson’s Disease in Clinical Study Design and Execution: A Call to ActionJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 4Start Page: 1359End Page: 1363Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-223190Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223190?id=journal-of-parkinsons-disease%2Fjpd223190Citation Count: 14
-
OPENTitle: Resequencing the complete SNCA locus in Indian patients with Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00676-4Best OA location URL: https://www.nature.com/articles/s41531-024-00676-4.pdfCitation Count: 2
- Predictors of stress resilience in Parkinson’s disease and associations with symptom progression2024OPENTitle: Predictors of stress resilience in Parkinson’s disease and associations with symptom progressionJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00692-4Best OA location URL: https://www.nature.com/articles/s41531-024-00692-4.pdfCitation Count: 11
-
OPENTitle: Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicityJournal Name: Cell Death & DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41419-020-03172-8Best OA location URL: https://www.nature.com/articles/s41419-020-03172-8.pdfCitation Count: 20
-
RESTRICTEDTitle: Structure-based optimization and binding assays for discovery of tau PET radiotracers: synthesis and in vivo evaluation of [11C]Z-3272Journal Name: Canadian Journal of ChemistryPublisher: Canadian Science PublishingVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1139/cjc-2025-0058Best OA location URL: https://doi.org/10.1139/cjc-2025-0058Citation Count: 0
-
OPENTitle: Identification of β-synuclein on secretory granules in chromaffin cells and the effects of α- and β-synuclein on post-fusion BDNF discharge and fusion pore expansionJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 699Issue #:Start Page: 134End Page: 139Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2019.01.056Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6443492Citation Count: 9
-
OPENTitle: Effect of olfactory bulb pathology on olfactory function in normal agingJournal Name: Brain PathologyPublisher: WileyVol: 32Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/bpa.13075Best OA location URL: https://doi.org/10.1111/bpa.13075Citation Count: 26
-
OPENTitle: White Matter Hyperintensities Related to Parkinson's Disease Executive FunctionJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 6Start Page: 629End Page: 638Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.12956Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12956Citation Count: 47
-
OPENTitle: Lifestyle Factors and Parkinson’s Disease Risk in a Rural New England Case-Control StudyJournal Name: Parkinson's DiseasePublisher: WileyVol: 2021Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2021/5541760Best OA location URL: https://downloads.hindawi.com/journals/pd/2021/5541760.pdfCitation Count: 5
-
OPENTitle: β2‐adrenoreceptor medications and risk of Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 84Issue #: 5Start Page: 683End Page: 693Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.25341Citation Count: 72
-
OPENTitle: T2-Imaging Changes in the Nigrosome-1 Relate to Clinical Measures of Parkinson’s DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 7Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2016.00174Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2016.00174/pdfCitation Count: 10
-
OPENTitle: Oligogenic structure of amyotrophic lateral sclerosis has genetic testing, counselling and therapeutic implicationsJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 96Issue #: 10Start Page: jnnpEnd Page: 335364Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1136/jnnp-2024-335364Best OA location URL: https://doi.org/10.1136/jnnp-2024-335364Citation Count: 5
-
OPENTitle: Genetic variants related to urate and risk of Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 53Issue #:Start Page: 4End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.04.031Best OA location URL: http://hdl.handle.net/10468/6191Citation Count: 6
-
OPENTitle: Genetic modulation of mitochondrial NAD+ regeneration does not prevent dopaminergic neuron dysfunction caused by mitochondrial complex I impairmentJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2025.1650462Best OA location URL: https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2025.1650462/pdfCitation Count: 0
-
OPENTitle: Impact of dyskinesia on activities of daily living in Parkinson's disease: Results from pooled phase 3 ADS-5102 clinical trialsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 60Issue #:Start Page: 118End Page: 125Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.09.005Best OA location URL: https://doi.org/10.1016/j.parkreldis.2018.09.005Citation Count: 29
- Anemia in men and increased Parkinson's disease risk: A population-based large scale cohort study2019RESTRICTEDTitle: Anemia in men and increased Parkinson's disease risk: A population-based large scale cohort studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 64Issue #:Start Page: 90End Page: 96Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.03.010Citation Count: 14
-
RESTRICTEDTitle: The footprint of orthostatic hypotension in parkinsonian syndromesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 77Issue #:Start Page: 107End Page: 109Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.029Citation Count: 7
-
RESTRICTEDTitle: A late-onset neurological disorder: is progression inevitable?Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 108Issue #:Start Page: 105092End Page: 105092Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.014Citation Count: 0
-
OPENTitle: Neuroprotective Strategies and Cell-Based Biomarkers for Manganese-Induced Toxicity in Human Neuroblastoma (SH-SY5Y) CellsJournal Name: BiomoleculesPublisher: MDPI AGVol: 14Issue #: 6Start Page: 647End Page: 647Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom14060647Best OA location URL: https://www.mdpi.com/2218-273X/14/6/647/pdf?version=1717136963Citation Count: 5
-
OPENTitle: Longitudinal dysregulation of long non-coding RNAs in Parkinson’s diseaseJournal Name: Experimental Biology and MedicinePublisher: Frontiers Media SAVol: 248Issue #: 20Start Page: 1780End Page: 1784Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/15353702231198078Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10792423/pdf/10.1177_15353702231198078.pdfCitation Count: 0
-
OPENTitle: Neurofilament light chain in spinal fluid and plasma in multiple system atrophy: a prospective, longitudinal biomarker studyJournal Name: Clinical Autonomic ResearchPublisher: Springer Science and Business Media LLCVol: 33Issue #: 6Start Page: 635End Page: 645Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10286-023-00974-6Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10840936/pdf/nihms-1925200.pdfCitation Count: 8
-
OPENTitle: MAPT Locus in Parkinson’s Disease Patients of Ashkenazi Origin: A Stratified AnalysisJournal Name: GenesPublisher: MDPI AGVol: 15Issue #: 1Start Page: 46End Page: 46Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/genes15010046Best OA location URL: https://www.mdpi.com/2073-4425/15/1/46/pdf?version=1703728220Citation Count: 1
-
OPENTitle: Reply to: Hypoxia treatment of Parkinson’s disease may disrupt the circadian systemJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 23Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-023-03281-9Best OA location URL: https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-023-03281-9Citation Count: 0
-
OPENTitle: Pre-clinical therapeutic development of a series of metalloporphyrins for Parkinson's diseaseJournal Name: Toxicology and Applied PharmacologyPublisher: Elsevier BVVol: 326Issue #:Start Page: 34End Page: 42Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.taap.2017.04.004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5704913Citation Count: 14
-
OPENTitle: A Novel Lead Design for Modulation and Sensing of Deep Brain StructuresJournal Name: IEEE Transactions on Biomedical EngineeringPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 63Issue #: 1Start Page: 148End Page: 157Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1109/tbme.2015.2492921Best OA location URL: http://doi.org/10.1109/TBME.2015.2492921Citation Count: 38